Thesis
Signal active
Organization
Contact Information
Overview
Thesis offers personalized brain supplements that cater to all types of brains. They create potent nutritional compounds to improve mental function and provide individualized suggestions depending on their customers' goals and brain chemistry.
About
Industries
Health Care, Pharmaceutical, Wellness
Founded
2017
Employees
11-50
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
Thesis headquartered in New York, New York, United States, North America, operates in the Health Care, Pharmaceutical, Wellness sector. The company focuses on Health Care and has secured $490.9M in funding across 36 round(s). With a team of 11-50 employees, Thesis is actively contributing to advancements in Health Care. Their latest funding round, Pre Seed Round - Thesis, raised $135.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
1
Lead Investors
0
Total Funding Amount
$13.6M
Details
3
Thesis has raised a total of $13.6M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 8.4M | ||
| 2023 | Seed | 5.1M | ||
| 2019 | Seed | 135.0K |
Investors
Thesis is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Unilever Ventures | - | FUNDING ROUND - Unilever Ventures | 5.1M |
| Thesis | - | FUNDING ROUND - Thesis | 5.1M |
| Thesis | - | FUNDING ROUND - Thesis | 135.0K |
| XRC Ventures | - | FUNDING ROUND - XRC Ventures | 135.0K |
Recent Activity
There is no recent news or activity for this profile.